Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 2, 2003, Pages 839-847

  Feeney, Susan A ^a   Simpson, David A C ^a   Gardiner, Thomas A ^a   Boyle, Cliona ^a   Jamison, Pamela ^a   Stitt, Alan W ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GROWTH FACTOR; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CORRELATION ANALYSIS; HYALOID ARTERY; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; OPHTHALMIC ARTERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RETINA BLOOD VESSEL; RETINA DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME SERIES ANALYSIS;

ANIMALS; ANIMALS, NEWBORN; ENDOTHELIAL GROWTH FACTORS; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY PROTEINS; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 0037308611     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0040     Document Type: Article

References (50)

1. Ashton N. Donders lecture, 1967. Some aspects of the comparative pathology of oxygen toxicity in the retina. Br J Ophthalmol. 1968;52:505-531.
2. McKenna DJ, Simpson DAC, Feeney S, et al. Expression of the 67kDa laminin receptor (67LR) during retinal development: correlations with angiogenesis. Exp Eye Res. 2001;73:81-92.
3. Friedlander M, Theesfeld CL, Sugita M, et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci USA. 1996;93:9764-9769.
4. Blanks JC, Johnson LV. Selective lectin binding of the developing mouse retina. J Comp Neurol. 1983;221:31-41.
5. Zhu M, Madigan MC, van Drie D, et al. The human hyaloid system: cell death and vascular regression. Exp Eye Res. 2000;70:767-776.
6. Provis JM, Leech J, Diaz CM, et al. Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res. 1997;65:555-468.
7. Chan-Ling T, Gock B, Stone J. The effect of oxygen on vasoformative cell division: evidence that "physiological hypoxia" is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci. 1995;36:1201-1214.
8. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738-4747.
9. Nicosia RF. What is the role of vascular endothelial growth factorrelated molecules in tumor angiogenesis? Am J Pathol. 1998;153:11-16.
10. Olofsson B, Pajusola K, von Euler G, et al. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem. 1996;271:19310-19317.
11. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
12. Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995;1:1024-1028.
13. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4-25.
14. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 1999;77:527-543.
15. Vinores SA, Derevjanik NL, Ozaki H, et al. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol. 1999;97:217-228.
16. Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001;7:575-583.
17. Clauss M, Weich H, Breier G, et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem. 1996;271:17629-17634.
18. Shibuya M, Ito N, Claesson-Welsh L. Structure and function of vascular endothelial growth factor receptor-1 and -2. Curr Top Microbiol Immunol. 1999;237:59-83.
19. Cao Y, Chen H, Zhou L, et al. Heterodimers of placenta growth factor/vascular endothelial growth factor: endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem. 1996;271:3154-3162.
20. Cunningham SA, Tran TM, Arrate MP, et al. Characterization of vascular endothelial cell growth factor interactions with the kinase insert domain-containing receptor tyrosine kinase: a real time kinetic study. J Biol Chem. 1999;274:18421-18427.
21. Park JE, Chen HH, Winer J, et al. Placenta growth factor: potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Fit-1 but not to Flt-1/. KDR. J Biol Chem. 1994;269:25646-25654.
22. Khaliq A, Li XF, Shams M, et al. Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors. 1996;13:243-250.
23. Clark DE, Smith SK, Licence D, et al. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol. 1998;159:459-467.
24. Simpson DAC, Murphy, GM, Bhaduri T, et al. Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia. Biochem Biophys Res Commun. 1999;262:333-340.
25. Ahmed A, Dunk C, Ahmad S, et al. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen: a review. Placenta. 2000; 21(suppl A):S16-S24.
26. Sone H, Kawakami Y, Segawa T, et al. Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy. Life Sci. 1999;65:2573-2580.
27. Gebarowska D, Stitt AW, Gardiner TA, Harriott P, Greer B, Nelson J. Synthetic peptides interacting with the 67kDa laminin receptor can reduce retinal ischaemia and inhibit hypoxia-induced retinal neovascularisation. Am J Pathol. 2002;160:307-313.
28. Simpson DAC, Feeney S, Boyle C, et al. Retinal VEGF mRNA measured by SYBR Green I fluorescence: a versatile approach to quantitative PCR. Mol Vis. 2000;6:178-183.
29. Morrison TB, Weis JJ, Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques. 1998;24:954-958.
30. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology. 1993;11:1026-1030.
31. Stitt AW, Simpson DAC, Boocock C, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intraocular tumours. J Pathol. 1998;186:306-312.
32. Campochiaro PA. Retinal and choroidal neovascularization. J Cell Physiol. 2000;184:301-310.
33. Miller JW, Adamis AP, Aiello LP. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev. 1997;13:37-50.
34. Vinores SA, Kuchle M, Mahlow J, et al. Blood-ocular barrier breakdown in eyes with ocular melanoma: a potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol. 1995;147:1289-1297.
35. Dvorak HF, Nagy JA, Feng D, et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol. 1999;237:97-132.
36. Breier G, Damert A, Plate KH, et al. Angiogenesis in embryos and ischemic diseases. Thromb Haemost. 1997;78:678-83.
37. Risau W, Flamme I. Vasculogenesis. Ann Rev Cell Dev Biol. 1995; 11:73-91.
38. Ash JD, Overbeek PA. Lens-specific VEGF-A expression induces angioblast migration and proliferation and stimulates angiogenic remodeling. Dev Biol. 2000;223:383-398.
39. Provis JM. Development of the primate retinal vasculature. Prog Retin Eye Res. 2001;20:799-821.
40. Connolly SE, Hores TA, Smith LE, et al. Characterization of vascular development in the mouse retina. Microvasc Res. 1988;36:275-290.
41. Khaliq A, Dunk C, Jiang J, et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab Invest. 1999; 79:151-170.
42. Yonekura H, Sakurai S, Liu X, et al. Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes: implication in autocrine and paracrine regulation of angiogenesis. J Biol Chem. 1999;274:35172-35178.
43. Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9-22.
44. Cao Y, Ji WR, Qi P, et al. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun. 1997;235:493-498.
45. Zeng H, Zhao D, Mukhopadhyay D. Flt-1-mediated down-regulation of endothelial cell proliferation through pertussis toxin-sensitive G proteins, beta gamma subunits, small GTPase CDC42, and partly by Rac-1. J Biol Chem. 2002;277:4003-4009.
46. Kearney JB, Ambler CA, Monaco KA, Johnson N, Rapoport RG, Bautch VL. Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood. 2002;99:2397-407.
47. Gluzman-Poltorak Z, Cohen T, Herzog Y, et al. Neuropilin-2 and neuropilin-1 are receptors for the 165-amino acid form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145-amino acid form of VEGF. J Biol Chem. 2000;275:18040-18045.
48. Migdal M, Huppertz B, Tessler S, et al. Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem. 1998;273:22272-22278.
49. Fuh G, Garcia KC, Vos, AM. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. J Biol Chem. 2000;275:26690-26695.
50. DiSalvo J, Bayne ML, Conn G, et al. Purification and characterization of a naturally occurring vascular endothelial growth factor: placenta growth factor heterodimer. J Biol Chem. 1995;270:7717-7723.